Sublingually Org 5222
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sublingually Org 5222, covering 2010-10-13 to 2010-10-13. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937) [Phase 2]